NLM Digital Collections

Search

Start Over Subjects Opioid-Related Disorders -- economics ✖Remove constraint Subjects: Opioid-Related Disorders -- economics

1. Abuse-deterrent formulations of opioids: effectiveness and value : final evidence report

Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, August 8, 2017
Subject(s):
Abuse-Deterrent Formulations -- economics
Abuse-Deterrent Formulations -- statistics & numerical data
Analgesics, Opioid -- economics
Analgesics, Opioid -- therapeutic use
Opioid-Related Disorders -- economics
Opioid-Related Disorders -- prevention & control
Prescription Drug Diversion -- statistics & numerical data
Comparative Effectiveness Research
Cost-Benefit Analysis
Delayed-Action Preparations -- economics
Delayed-Action Preparations -- therapeutic use
Drug Compounding -- economics
Drug Overdose -- mortality
Insurance Coverage -- economics
Insurance, Pharmaceutical Services -- economics
Opioid-Related Disorders -- epidemiology
Humans
United States

2. Restructuring Medicaid in the American Health Care Act: five key considerations

Author(s):
Paradise, Julia, author
Publication:
Menlo Park, CA : Henry J. Kaiser Family Foundation, March 2017
Subject(s):
Health Care Reform -- economics
Medicaid -- economics
Capitation Fee
Federal Government
Health Care Reform -- legislation & jurisprudence
Medicaid -- legislation & jurisprudence
Long-Term Care -- economics
Opioid-Related Disorders -- economics
State Government
Humans
United States

3. Management of patients with opioid dependence: a review of clinical, delivery system, and policy options

Publication:
[Boston, MA] : Institute for Clinical and Economic Review, July 2014
Subject(s):
Analgesics, Opioid -- therapeutic use
Buprenorphine -- therapeutic use
Comparative Effectiveness Research
Delivery of Health Care
Health Policy
Methadone -- therapeutic use
Naloxone -- therapeutic use
Naltrexone -- therapeutic use
Opiate Substitution Treatment -- economics
Opioid-Related Disorders -- drug therapy
Opioid-Related Disorders -- economics
Opioid-Related Disorders -- rehabilitation
Analgesics, Opioid -- administration & dosage
Analgesics, Opioid -- adverse effects
Budgets
Cohort Studies
Cost-Benefit Analysis
Counseling
Criminal Law
Drug Combinations
Drug Costs
Health Services Accessibility
Insurance Coverage
Medicaid
Medicare
Patient Care Team
Patient-Centered Care
Practice Guidelines as Topic
Treatment Outcome
Humans
New England
United States

4. Show me the money: economic evaluations of opioid use disorder interventions

Author(s):
Murphy, Sean M., author
Polsky, Daniel, author
Meisel, Zachary, author
Mitchell, Julia, author
Publication:
Philadelphia, PA : Leonard Davis Institute of Health Economics, May 2016
Subject(s):
Opioid-Related Disorders -- drug therapy
Opioid-Related Disorders -- economics
Buprenorphine -- therapeutic use
Cost-Benefit Analysis
Methadone -- therapeutic use
Naltrexone -- therapeutic use
Reward
Humans
United States

5. Stem the tide: addressing the opioid epidemic

Publication:
Chicago, IL : American Hospital Association, [2017]
Subject(s):
Analgesics, Opioid -- therapeutic use
Opioid-Related Disorders -- epidemiology
Opioid-Related Disorders -- prevention & control
Opioid-Related Disorders -- therapy
Pain Management -- methods
Inappropriate Prescribing -- prevention & control
Opioid-Related Disorders -- economics
Pain -- drug therapy
Patient Education as Topic
Patient Transfer
Practice Patterns, Physicians'
Humans
United States

6. The ABCs of APCDs: how states are using claims data to understand and improve care

Author(s):
Porter, Josephine, author
Love, Denise, author
Publication:
[Oakland, Calif.] : California Health Care Foundation, November 2018
Subject(s):
Databases as Topic
Health Expenditures -- statistics & numerical data
Insurance Claim Review
Chronic Disease -- economics
Cost of Illness
Drug Costs
Health Care Costs
Inappropriate Prescribing -- prevention & control
Opioid-Related Disorders -- economics
Opioid-Related Disorders -- epidemiology
State Government
Humans
California
United States

8. Workforce Innovation And Opportunity Act: additional DOL actions needed to help states and employers address substance use disorder : report to Congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, May 2020
Subject(s):
Financing, Government -- organization & administration
Government Regulation
Opioid-Related Disorders -- economics
Workforce -- legislation & jurisprudence
United States
United States. Department of Labor

9. Opioid use in Medicare Part D continued to decline in 2019, but vigilance is needed as COVID-19 raises new concerns

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, August 2020
Subject(s):
COVID-19 -- economics
Fraud -- prevention & control
Government Regulation
Medicare Part D -- organization & administration
Opioid-Related Disorders -- economics
United States
United States. Department of Health and Human Services

10. FDA’s risk evaluation and mitigation strategies: uncertain effectiveness in addressing the opioid crisis

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2020
Subject(s):
Government Regulation
Opioid-Related Disorders -- economics
Risk Evaluation and Mitigation -- legislation & jurisprudence
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration